Bob O’Donnell, president and chief analyst at Technalysis Research, outlines market sentiment toward the U.S. artificial intelligence tech giant.
Bob O’Donnell, president and chief analyst at Technalysis Research, outlines market sentiment toward the U.S. artificial intelligence tech giant.
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024